Skip to main content

Drug Utilization Over Time for Six Drug Classes

Basic Details
Date Posted
Status
Complete
Medical Product
ace inhibitors
beta blockers
granulocyte colony-stimulating factor (GC-SF)
intravenous (IV) iron
statins
tumor necrosis factor (TNF) alpha inhibitor
Description

This query investigated the use of tumor necrosis factor (TNF) alpha inhibitor drugs, granulocyte colony-stimulating factor (GC-SF) drugs, intravenous iron, statin drugs, angiotensin converting enzyme (ACE) inhibitor drugs, and beta blocker drugs. The study period includes data from January 1, 2011 to December 31, 2015. We distributed the request for TNF alpha inhibitor drugs, GC-SF drugs, and intravenous iron to 16 Sentinel Data Partners on August 10, 2016. We distributed the request for statin drugs, ACE inhibitor drugs, and beta blocker drugs to 15 Sentinel Data Partners on June 17, 2016.

Deliverables (6)
Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Tumor Necrosis Factor Alpha Inhibitor Drugs Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Granulocyte Colony-Stimulating Factor Drugs Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Intravenous Iron Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Statin Drugs Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Angiotensin Converting Enzyme Inhibitor Drugs Sentinel Modular Program Report: Drug Utilization Over Time for Six Drug Classes: Beta Blocker Drugs
Additional Details
FDA Center
CDER
Time Period
January 1, 2011 - December 31, 2015
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization